Aramark Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Aramark on June 4, 2014, regarding events occurring on May 29, 2014. The filing details the entry into a material definitive agreement for an underwritten secondary offering of common stock by selling stockholders.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or debt levels. The financial data presented relates exclusively to the terms of the secondary stock offering:
- Shares Sold: 20,000,000 shares initially, plus 3,000,000 additional shares via option exercise, totaling 23,000,000 shares.
- Offering Price: $25.50 per share to the public.
- Price to Selling Stockholders: $24.54375 per share.
- Proceeds: All net proceeds were received by the Selling Stockholders. No shares were sold by Aramark, and the Company received no proceeds from this transaction.
Material Changes
The primary material change is the execution of an Underwriting Agreement with Goldman, Sachs & Co., J.P. Morgan Securities LLC, Credit Suisse Securities (USA) LLC, and Morgan Stanley & Co. LLC. The underwriters exercised their option to purchase the additional 3,000,000 shares in full on May 30, 2014. The offering officially closed on June 4, 2014.
Guidance, Outlook, and Risks
The filing contains no management guidance, outlook, or commentary on future business performance. The primary contingency noted is the Company's agreement to indemnify the Underwriters against certain liabilities under the Securities Act of 1933 or to contribute to payments required by the Underwriters due to such liabilities.
Key Facts for Investor Verification
- Verify that the 23,000,000 shares sold were exclusively from Selling Stockholders and did not involve the issuance of new shares by Aramark.
- Confirm that the Company received zero net proceeds from this transaction.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific indemnification obligations and covenants.
- Check subsequent filings for any impact on the Company's capital structure or share count resulting from this secondary offering.